Adimmune Corp
TWSE:4142
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
J
|
Johnson & Johnson
BMV:JNJ
|
US |
Adimmune Corp
Inventory
Adimmune Corp
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Adimmune Corp
TWSE:4142
|
Inventory
NT$786.1m
|
CAGR 3-Years
2%
|
CAGR 5-Years
5%
|
CAGR 10-Years
2%
|
|
|
GenMont Biotech Inc
TWSE:3164
|
Inventory
NT$70.4m
|
CAGR 3-Years
8%
|
CAGR 5-Years
15%
|
CAGR 10-Years
3%
|
|
|
E
|
Energenesis Biomedical Co Ltd
TWSE:6657
|
Inventory
NT$864k
|
CAGR 3-Years
13%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
Pell Bio Med Technology Co Ltd
TWSE:6949
|
Inventory
NT$6.6m
|
CAGR 3-Years
13%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Kim Forest Enterprise Co Ltd
TWSE:6645
|
Inventory
NT$139.2m
|
CAGR 3-Years
17%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
Adimmune Corp
Glance View
ADIMMUNE CORPORATION is a Taiwan-based company principally engaged in the research and development, processing, manufacture and trading of influenza vaccine products and non-flu vaccine products. The Company's products include Japanese encephalitis vaccines, tetanus vaccines, influenza vaccines, H1N1 influenza vaccines and tuberculin. The vaccine products are applied in the prevention of various infectious viruses. The tuberculin is applied in tuberculin purified protein derivative (PPD) test. The Company distributes its products within domestic market and to overseas markets, including other markets in Asia, Europe and Africa.
See Also
What is Adimmune Corp's Inventory?
Inventory
786.1m
TWD
Based on the financial report for Sep 30, 2025, Adimmune Corp's Inventory amounts to 786.1m TWD.
What is Adimmune Corp's Inventory growth rate?
Inventory CAGR 10Y
2%
Over the last year, the Inventory growth was -7%. The average annual Inventory growth rates for Adimmune Corp have been 2% over the past three years , 5% over the past five years , and 2% over the past ten years .
